Risk of Guillain-Barre Syndrome and H1N1 Influenza Vaccination

Abstract

Researchers at Laval University, Department of Pediatric Neurology (Dr Boucher), Quebec University Hospital and other centers in Montreal, Quebec, Canada assessed the risk of Guillain-Barre syndrome (GBS) following the pandemic influenza vaccination campaign in 2009, mostly using an AS03 adjuvant vaccine.

Keywords

• guillain-barre syndrome
• influenza a (h1n1) vaccination
• fluvax